These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 6817709)
1. Antiviral and side effects of interferons produced by recombinant DNA techniques as tested in rhesus monkeys. Schellekens H; van Eerd PM; de Reus A; Weck PK; Stebbing N Antiviral Res; 1982 Oct; 2(5):313-8. PubMed ID: 6817709 [TBL] [Abstract][Full Text] [Related]
2. The effects of recombinant and natural human interferons in vaccinia virus infected rhesus monkeys. van der Meide PH; Harteveld N; Stebbing N; Schellekens H Antiviral Res; 1985; Suppl 1():199-207. PubMed ID: 3936413 [No Abstract] [Full Text] [Related]
3. Recombinant HuIFN-gamma prevents herpes simplex keratitis in African green monkeys: demonstration of synergism with recombinant HuIFN-alpha 2. Neumann-Haefelin D; Sundmacher R; Frey H; Merk W Med Microbiol Immunol; 1985; 174(2):81-6. PubMed ID: 3929044 [TBL] [Abstract][Full Text] [Related]
4. Comparative antiviral efficiency of leukocyte and bacterially produced human alpha-interferon in rhesus monkeys. Schellekens H; de Reus A; Bolhuis R; Fountoulakis M; Schein C; Ecsödi J; Nagata S; Weissmann C Nature; 1981 Aug; 292(5825):775-6. PubMed ID: 6167863 [No Abstract] [Full Text] [Related]
5. Recombinant interferons alpha and gamma: comparative antiviral activity and synergistic interaction in encephalomyocarditis virus infection of mice. Sim IS; Cerruti RL Antiviral Res; 1987 Nov; 8(4):209-21. PubMed ID: 3128162 [TBL] [Abstract][Full Text] [Related]
6. The interferon system as a basis for antiviral therapy or prophylaxis. Billiau A Antiviral Res; 1985; Suppl 1():131-40. PubMed ID: 3936410 [No Abstract] [Full Text] [Related]
7. Recombinant fibroblast interferon and immune interferon for treating chronic hepatitis B virus infection: patients' tolerance and the effect on viral markers. Bissett J; Eisenberg M; Gregory P; Robinson WS; Merigan TC J Infect Dis; 1988 May; 157(5):1076-80. PubMed ID: 3129521 [No Abstract] [Full Text] [Related]
8. Biological and clinical effects of the combination of beta- and gamma-interferons administered as a 5-day continuous infusion. Schiller JH; Storer B; Witt PL; Nelson B; Brown RR; Horisberger M; Grossberg S; Borden EC Cancer Res; 1990 Aug; 50(15):4588-94. PubMed ID: 2114942 [TBL] [Abstract][Full Text] [Related]
9. Receptors for human alpha and beta interferon but not for gamma interferon are specified by human chromosome 21. Raziuddin A; Sarkar FH; Dutkowski R; Shulman L; Ruddle FH; Gupta SL Proc Natl Acad Sci U S A; 1984 Sep; 81(17):5504-8. PubMed ID: 6206498 [TBL] [Abstract][Full Text] [Related]
10. Recombinant human interferon-gamma modulates Rift Valley fever virus infection in the rhesus monkey. Morrill JC; Czarniecki CW; Peters CJ J Interferon Res; 1991 Oct; 11(5):297-304. PubMed ID: 1774469 [TBL] [Abstract][Full Text] [Related]
11. Prevention of Rift Valley fever in rhesus monkeys with interferon-alpha. Morrill JC; Jennings GB; Cosgriff TM; Gibbs PH; Peters CJ Rev Infect Dis; 1989; 11 Suppl 4():S815-25. PubMed ID: 2546250 [TBL] [Abstract][Full Text] [Related]
12. Antiviral effect of bacterially produced human interferon (Hu-IFN alpha 2) against experimental vaccinia infection in calves. Werenne J; Vanden Broecke C; Schwers A; Goossens A; Bugyaki L; Maenhoudt M; Pastoret PP J Interferon Res; 1985; 5(1):129-36. PubMed ID: 3989335 [TBL] [Abstract][Full Text] [Related]
13. Qualitative differences in effects of recombinant alpha-, beta- and gamma-interferons on human peripheral blood leukocytes in vitro. Billard C; Ferbus D; Kolb JP; Rosa F; Perrot JY; Merlin G; Janiaud P; Raynaud N; Thang MN; Fellous M Ann Inst Pasteur Immunol (1985); 1986; 137C(3):259-72. PubMed ID: 3090926 [TBL] [Abstract][Full Text] [Related]
14. Differences in natural and recombinant interferon for herpes keratitis in two animal models. Sanitato JJ; Varnell ED; Kaufman HE; Raju VK Invest Ophthalmol Vis Sci; 1984 Jul; 25(7):874-6. PubMed ID: 6735652 [TBL] [Abstract][Full Text] [Related]
15. Antiviral effects of bacteria-derived human leukocyte interferons against encephalomyocarditis virus infection of squirrel monkeys. Brief report. Stebbing N; Weck PK; Fenno JT; Estell DA; Rinderknecht E Arch Virol; 1983; 76(4):365-72. PubMed ID: 6312932 [TBL] [Abstract][Full Text] [Related]
16. Prevention of vaccinia lesions in Rhesus monkeys by human leucocyte and fibroblast interferon. Weimar W; Stitz L; Billiau A; Cantell K; Schellekens H J Gen Virol; 1980 May; 48(1):25-30. PubMed ID: 6155433 [TBL] [Abstract][Full Text] [Related]
17. Treatment of multiple sclerosis with various interferons: the cons. Johnson KP Neurology; 1988 Jul; 38(7 Suppl 2):62-5. PubMed ID: 3133576 [TBL] [Abstract][Full Text] [Related]
18. Interferon system of human cornea cells: interferon production, characterization, and development of antiviral state. Thacore HR; Mount DT; Chadha KC J Interferon Res; 1982; 2(3):401-8. PubMed ID: 6182255 [TBL] [Abstract][Full Text] [Related]
19. Response to the combined administration of interferons alpha and gamma after failure of single interferon therapy in chronic myelogenous leukaemia. Kloke O; Becher R; Niederle N Blut; 1987 Nov; 55(5):453-8. PubMed ID: 3118992 [TBL] [Abstract][Full Text] [Related]